Loading...
BRAF-inhibition and tumor immune suppression
As BRAF(V600E)-inhibitors become standard treatment for many metastatic melanoma patients, research has begun to elucidate their impact on the tumor immune landscape. Here, we highlight our recent studies demonstrating the ability of melanoma cell-intrinsic BRAF(V600E)-inhibition to selectively redu...
Na minha lista:
| Udgivet i: | Oncoimmunology |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Taylor & Francis
2015
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404921/ https://ncbi.nlm.nih.gov/pubmed/25949884 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/2162402X.2014.988039 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|